Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,351
datasets available to search
ShareScore release 0.9.0
Dataset results
1,351 results for “Intermediates”
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT03035344. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis
ClinicalTrials.gov study NCT01030328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer
ClinicalTrials.gov study NCT04870567. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02435953. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
ClinicalTrials.gov study NCT02023463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genes, Intermediate Phenotypes and Response to Quetiapine RX
ClinicalTrials.gov study NCT01044914. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.
ClinicalTrials.gov study NCT06855589. IPD Sharing: NO. Countries: 1. Publications: 0.
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
ClinicalTrials.gov study NCT05361902. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer
ClinicalTrials.gov study NCT02499848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
ClinicalTrials.gov study NCT03914794. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT06331299. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
ClinicalTrials.gov study NCT00404742. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly
ClinicalTrials.gov study NCT01692366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT06510374. IPD Sharing: NO. Countries: 5. Publications: 0.
A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
ClinicalTrials.gov study NCT07317700. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06990321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients
ClinicalTrials.gov study NCT00748384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
ClinicalTrials.gov study NCT05454488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
STUDY OF PREFERENCES IN MEN FACED WITH THE DIFFERENT TREATMENT OPTIONS FOR LOCALIZED PROSTRATE CANCER WITH A GOOD OR INTERMEDIATE PROGNOSIS
ClinicalTrials.gov study NCT02080793. IPD Sharing: Not stated. Countries: 1. Publications: 0.
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
ClinicalTrials.gov study NCT06468033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.